NMR-based metabolomics platform for studies worldwide.
Our platform offers scalable, batch-effect free, comprehensive metabolic analysis to accelerate scientific breakthroughs.
Our biomarker panel provides a comprehensive view of an individual’s overall health. This data, or a combination of it with other omics, can be used to discover novel associations between different areas of health, evaluate effects of drug and lifestyle interventions.
The data is batch-effects free and used by large cohorts worldwide, making it highly suitable for validation and replication studies.
Our clinically validated CE-marked biomarkers including ApoA-1, ApoB, routine lipids and glucose help move academic findings to a clinical context, while our additional markers help to further explain the molecular mechanisms associated with chronic diseases.
Nightingale’s biomarkers provide a broad view of an individual's overall health by including clinically established and emerging metabolic markers in numerous pathways.
We can analyze samples in 3 fully automated labs, located in Pittsburgh PA (USA), Helsinki and Kuopio (Finland). All of these labs operate under a certified quality management system and use high-throughput NMR spectroscopy. These ensure efficient, reproducible and affordable analysis without batch effects.
Deelen et al., NAT COMMUN 2019;10:3346
Locke et al. Nature 2019; Jul 31
Sliz et al. Circulation. 2018;138:2499–2512
Whether you have a question or you would like to ask for an offer, let us know and we'll get back to you very soon.